Advertisement

Topics

AML Market to Surpass $1.5B by 2026

16:00 EDT 2 Aug 2017 | Drug Discovery Development

By 2026, the branded AML market leader will be Venclexta, with estimated total sales of $179 million in the 7MM.
Contributed Author: 
GlobalData
Topics: 

Original Article: AML Market to Surpass $1.5B by 2026

NEXT ARTICLE

More From BioPortfolio on "AML Market to Surpass $1.5B by 2026"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...